Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -18,657 | -59,277 | -44,700 |
| Depreciation Amortization | 447 | 120 | 700 |
| Accounts payable and accrued liabilities | 1,044 | N/A | 795 |
| Other Working Capital | -561 | 1,791 | 4,806 |
| Other Operating Activity | -647 | 2,806 | 465 |
| Operating Cash Flow | $-18,374 | $-54,560 | $-37,934 |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -672 | -647 |
| Purchase Sale Intangibles | N/A | N/A | -147 |
| Other Investing Activity | 0 | -229 | -147 |
| Investing Cash Flow | $N/A | $-901 | $-794 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -110 | N/A | -55 |
| Common Stock Issued | 12 | N/A | 304 |
| Other Financing Activity | 0 | 189 | 21 |
| Financing Cash Flow | $-98 | $189 | $270 |
| Beginning Cash Position | 80,588 | 135,860 | 135,860 |
| End Cash Position | 62,116 | 80,588 | 97,402 |
| Net Cash Flow | $-18,472 | $-55,272 | $-38,458 |
| Free Cash Flow | |||
| Operating Cash Flow | -18,374 | -54,560 | -37,934 |
| Capital Expenditure | N/A | N/A | -647 |
| Free Cash Flow | -18,374 | -54,560 | -38,581 |